A study of 1,206 adults using full overnight polysomnography found that both current smokers and former smokers had approximately 75% greater odds of more severe obstructive sleep apnea compared to people who never smoked — suggesting that airway changes from smoking persist years after quitting.
The FDA granted premarket approval to LivaNova's aura6000, the first hypoglossal nerve stimulation device for sleep apnea that does not exclude patients with complete concentric collapse of the airway.
A Vanderbilt and Harvard study found that up to 69% of former NFL players may have sleep apnea — most of it undiagnosed — and that untreated cases are strongly linked to the cognitive and psychiatric symptoms often attributed to concussion-related brain damage.
A study of nearly 2.9 million people in the UK found that those with obstructive sleep apnea had a 71% higher risk of cardiovascular events or death compared to matched controls — and elevated rates of obesity, diabetes, and mental health conditions.
A Mount Sinai study published in Nature Communications Medicine introduces a machine learning model that can predict whether CPAP therapy will reduce or increase cardiovascular risk for individual sleep apnea patients — a first step toward personalized treatment decisions.
A review in Respirology finds that four distinct biological mechanisms drive obstructive sleep apnea in different patients, and that matching treatments to each mechanism could transform care — especially for the millions who abandon CPAP.
A Yale study of nearly 1 million U.S. veterans found that people with both insomnia and obstructive sleep apnea face nearly four times the risk of cardiovascular disease compared to those without either condition.